PL3344281T3 - Kompozycja farmaceutyczna zawierająca najmniej jeden enzym trawienny do stosowania w sztucznym żywieniu - Google Patents

Kompozycja farmaceutyczna zawierająca najmniej jeden enzym trawienny do stosowania w sztucznym żywieniu

Info

Publication number
PL3344281T3
PL3344281T3 PL16759756T PL16759756T PL3344281T3 PL 3344281 T3 PL3344281 T3 PL 3344281T3 PL 16759756 T PL16759756 T PL 16759756T PL 16759756 T PL16759756 T PL 16759756T PL 3344281 T3 PL3344281 T3 PL 3344281T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
composition containing
digestive enzyme
artificial nutrition
nutrition
Prior art date
Application number
PL16759756T
Other languages
English (en)
Inventor
Kristin Forssmann
Original Assignee
Nordmark Arzneimittel Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Arzneimittel Gmbh & Co.Kg filed Critical Nordmark Arzneimittel Gmbh & Co.Kg
Publication of PL3344281T3 publication Critical patent/PL3344281T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16759756T 2015-09-04 2016-08-31 Kompozycja farmaceutyczna zawierająca najmniej jeden enzym trawienny do stosowania w sztucznym żywieniu PL3344281T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102015114859.5A DE102015114859A1 (de) 2015-09-04 2015-09-04 Verwendung einer pharmazeutischen Zusammensetzung, enthaltend mindestens ein Verdauungsenzym, bei der künstlichen Ernährung
PCT/EP2016/070516 WO2017037114A1 (de) 2015-09-04 2016-08-31 Verwendung einer pharmazeutischen zusammensetzung, enthaltend mindestens ein verdauungsenzym, bei der künstlichen ernährung
EP16759756.6A EP3344281B1 (de) 2015-09-04 2016-08-31 Pharmazeutische zusammensetzung, enthaltend mindestens ein verdauungsenzym, zur verwendung bei der künstlichen ernährung

Publications (1)

Publication Number Publication Date
PL3344281T3 true PL3344281T3 (pl) 2021-04-19

Family

ID=56852265

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16759756T PL3344281T3 (pl) 2015-09-04 2016-08-31 Kompozycja farmaceutyczna zawierająca najmniej jeden enzym trawienny do stosowania w sztucznym żywieniu

Country Status (6)

Country Link
US (1) US10973886B2 (pl)
EP (1) EP3344281B1 (pl)
DE (1) DE102015114859A1 (pl)
ES (1) ES2858307T3 (pl)
PL (1) PL3344281T3 (pl)
WO (1) WO2017037114A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11987823B2 (en) 2019-08-30 2024-05-21 Societe Des Produits Nestle S.A. Engineered lipase variants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602910A (en) * 1984-02-28 1986-07-29 Larkin Mark E Compartmented flexible solution container
US5098378A (en) * 1989-06-02 1992-03-24 Abbott Laboratories Method of jejunal feeding
WO1993000924A1 (de) 1991-07-01 1993-01-21 Basf Aktiengesellschaft Verwendung von lipasen zur herstellung von arzneimitteln
US5527280A (en) * 1995-03-29 1996-06-18 The Children's Seashore House Multi-lumen enteral feeding and medicating device
DE10243208B4 (de) * 2002-09-18 2005-02-10 Fresenius Kabi Deutschland Gmbh Dreilumige gastrointestinale Sonde
AU2005295754B2 (en) 2004-10-14 2010-09-09 Eli Lilly And Co. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
UA10025U (en) * 2005-05-31 2005-10-17 Bohomolets Nat Medical Univers Method for preventing early postoperative gastrointestinal bleeding in patients fed enterally
AU2008239737A1 (en) * 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
DE102009006594A1 (de) * 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
JP2016513634A (ja) 2013-03-15 2016-05-16 アプタリス ファーマ リミテッド 消化酵素および栄養素を含む経腸投与に適した組成物

Also Published As

Publication number Publication date
US20180236040A1 (en) 2018-08-23
US10973886B2 (en) 2021-04-13
ES2858307T3 (es) 2021-09-30
EP3344281A1 (de) 2018-07-11
DE102015114859A1 (de) 2017-03-09
WO2017037114A1 (de) 2017-03-09
EP3344281B1 (de) 2020-12-09

Similar Documents

Publication Publication Date Title
IL258082B (en) History of benzaimidazole and pharmaceutical preparations containing them
IL256085B (en) A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment
ZA201802125B (en) Pharmaceutical composition and application thereof
IL269061A (en) A pharmaceutical preparation containing Selexifag
SG11201705395SA (en) Composition containing chitin and digestible proteins
IL243927A0 (en) A digestive enzyme preparation suitable for administration to the intestine
IL265970B (en) Sulfoxyalkyl organonitro compounds and related compounds and pharmaceutical preparations for use in medicine
IL250267A0 (en) History of indolizine, their preparation and pharmaceutical preparations containing them
EP3368498A4 (en) ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS
LT3278801T (lt) Farmacinė kompozicija, turinti mirabegrono
PT3344270T (pt) Composição que contém um extrato de echinacea e derivados de ácido linoleico
EP3275452A4 (en) Pharmaceutical composition containing silibinin
ZA201703398B (en) Pharmaceutical composition and methods
PL3129057T3 (pl) Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu
SG10202106375UA (en) Pharmaceutical compositions and use thereof
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
IL280389A (en) Bile acid receptor modulators conjugated to G.1 protein and methods of using them
IL254711B (en) History of diazepine-indole and medicinal preparations containing them
ZA201700278B (en) Pharmaceutical composition containing docetaxel
SMT202200483T1 (it) Composizione farmaceutica contenente aprepitant e metodo per la sua preparazione
PL3344281T3 (pl) Kompozycja farmaceutyczna zawierająca najmniej jeden enzym trawienny do stosowania w sztucznym żywieniu
GB201519644D0 (en) Therapy and pharmaceutical composition
EP3210614A4 (en) Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
IL237283A0 (en) Dldh and its derivatives, and preparations containing them for medical use
PL3072529T3 (pl) Kompozycja zawierająca wemurafenib i HPMC-AS